Rigel Pharmaceuticals, Inc. (RIGL)
NASDAQ · Healthcare
Rigel Pharmaceuticals, Inc. annual/quarterly long term debt history from 2019 to 2025. Long term debt refers to financial obligations that are due more than one year in the future.
- Rigel Pharmaceuticals, Inc. long term debt for the quarter ending December 31, 2025 were 52.5M, a 12.50% decrease year-over-year.
- Rigel Pharmaceuticals, Inc. long term debt for 2025 were 52.5M, a 12.50% decrease from 2024.
- Rigel Pharmaceuticals, Inc. long term debt for 2024 were 60.0M, a 0.00% increase from 2023.
- Rigel Pharmaceuticals, Inc. long term debt for 2023 were 60.0M, a 50.00% increase from 2022.
- Rigel Pharmaceuticals, Inc. long term debt for 2022 were 40.0M.
Long Term Debt
QUARTERLY · $B
YOY QUARTERLY GROWTH · %
| Rigel Pharmaceuticals, Inc. Annual Long Term Debt (Millions of US $) | |
|---|---|
| 2025 | $53 |
| 2024 | $60 |
| 2023 | $60 |
| 2022 | $40 |
| 2021 | $20 |
| 2020 | $20 |
| 2019 | $10 |
| Rigel Pharmaceuticals, Inc. Quarterly Long Term Debt (Millions of US $) | |
|---|---|
| 2025-12-31 | $53 |
| 2024-12-31 | $60 |
| 2023-12-31 | $60 |
| 2022-12-31 | $40 |
| 2021-12-31 | $20 |
| 2020-12-31 | $20 |
| 2019-12-31 | $10 |
Rigel Pharmaceuticals, Inc. Long Term Debt — FAQ
Rigel Pharmaceuticals, Inc. (RIGL) long term debt over the last 10 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see RIGL's long term debt history?
The chart and table above show Rigel Pharmaceuticals, Inc.'s long term debt by year and by quarter, including the growth rate.